Herbas VPB

Print
EN | LT
LT - Monokloninis antikūnas prieš CTLA4 ar antigeną surišantis jo fragmentas, gydomoji kompozicija ir panaudojimas
EN - ANTI-CTLA4 MONOCLONAL ANTIBODY OR ANTIGEN BINDING FRAGMENT THEREOF, MEDICINAL COMPOSITION AND USE

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07K 16/28 (2006.01)
C12N 15/13 (2006.01)
A61K 39/395 (2006.01)
A61P 35/00 (2006.01)
A61P 37/04 (2006.01)
G01N 33/577 (2006.01)
C12N 1/21 (2006.01)
C12N 5/10 (2006.01)
C12N 15/63 (2006.01)
C07K 19/00 (2006.01)
European patent
(11) Number of the document 3176181
(13) Kind of document T
(96) European patent application number 15827441.5
Date of filing the European patent application 2015-07-31
(97) Date of publication of the European application 2017-06-07
(45) Date of publication and mention of the grant of the patent 2020-12-23
(46) Date of publication of the claims translation 2021-04-12
PCT application
(86) Number PCT/CN2015/085721
Date 2015-07-31
PCT application publication
(87) Number WO 2016/015675
Date 2016-02-04
Priority applications
(30) Number Date Country code
201410377352 2014-08-01 CN
Inventors
(72)
LI, Baiyong, CN
XIA, Yu, CN
WANG, Zhongmin, CN
ZHANG, Peng, CN
PANG, Xinghua, CN
Grantee
(73) Akeso Biopharma Inc., 6 Shennong Boulevard Torch Developmental Zone, Zhongshan, Guangdong 528437, CN
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) Monokloninis antikūnas prieš CTLA4 ar antigeną surišantis jo fragmentas, gydomoji kompozicija ir panaudojimas
  ANTI-CTLA4 MONOCLONAL ANTIBODY OR ANTIGEN BINDING FRAGMENT THEREOF, MEDICINAL COMPOSITION AND USE
Last renewal fee
Payment date Validity (years) Amount
2025-06-16 11 289.00 EUR
Next renewal fee
2026-07-31